Dissemin is shutting down on January 1st, 2025

Published in

Elsevier, Journal of Vascular Surgery, 1(74), p. 336, 2021

DOI: 10.1016/j.jvs.2021.04.010

American Heart Association, Stroke, 3(52), p. 821-829, 2021

DOI: 10.1161/strokeaha.120.031579

Links

Tools

Export citation

Search in Google Scholar

Clinical Features of Patients With Cervical Artery Dissection and Fibromuscular Dysplasia

Journal article published in 2021 by Giorgio Silvestrelli, Sonia Bonacina, Claudio Baracchini, Paolo Cerrato, Corrado Lodigiani, Simona Marcheselli ORCID, Maurizio Paciaroni ORCID, Maurizia Rasura, Manuel Cappellari ORCID, Mario Grassi, Massimo Del Sette, Anna Cavallini ORCID, Andrea Morotti ORCID, Giuseppe Micieli ORCID, Enrico Maria Lotti and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

Background and Purpose: Observational studies have suggested a link between fibromuscular dysplasia and spontaneous cervical artery dissection (sCeAD). However, whether patients with coexistence of the two conditions have distinctive clinical characteristics has not been extensively investigated. Methods: In a cohort of consecutive patients with first-ever sCeAD, enrolled in the setting of the multicenter IPSYS CeAD study (Italian Project on Stroke in Young Adults Cervical Artery Dissection) between January 2000 and June 2019, we compared demographic and clinical characteristics, risk factor profile, vascular pathology, and midterm outcome of patients with coexistent cerebrovascular fibromuscular dysplasia (cFMD; cFMD+) with those of patients without cFMD (cFMD–). Results: A total of 1283 sCeAD patients (mean age, 47.8±11.4 years; women, 545 [42.5%]) qualified for the analysis, of whom 103 (8.0%) were diagnosed with cFMD+. In multivariable analysis, history of migraine (odds ratio, 1.78 [95% CI, 1.13–2.79]), the presence of intracranial aneurysms (odds ratio, 8.71 [95% CI, 4.06–18.68]), and the occurrence of minor traumas before the event (odds ratio, 0.48 [95% CI, 0.26–0.89]) were associated with cFMD. After a median follow-up of 34.0 months (25th to 75th percentile, 60.0), 39 (3.3%) patients had recurrent sCeAD events. cFMD+ and history of migraine predicted independently the risk of recurrent sCeAD (hazard ratio, 3.40 [95% CI, 1.58–7.31] and 2.07 [95% CI, 1.06–4.03], respectively) in multivariable Cox proportional hazards analysis. Conclusions: Risk factor profile of sCeAD patients with cFMD differs from that of patients without cFMD. cFMD and migraine are independent predictors of midterm risk of sCeAD recurrence.